NEUWAY Pharma GmbH

📍 Bonn, Germany🗓 Founded 2014👥 15 employees💰 Last funded 2022
Research Services🌐 neuway-pharma.com
Website LinkedIn
NEUWAY Pharma is committed to bringing transformative biopharmaceuticals across the blood-brain barrier through its EnPC®, the drug delivery technology based on a natural derived protein capsule. In addition to advancing its proprietary pipeline, the company aims to be a partner of choice in particular for antibody and mRNA drug developers stymied by the hurdles of delivering these and other drug modalities into the brain and CNS tissue. Operating as a drug developer and a delivery expert, NEUWAY will demonstrate the value of its technology through its internal orphan neurological disease pipeline and partnered programs.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2014
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
France
1
Frequently asked questions
Who invested in NEUWAY Pharma GmbH?
NEUWAY Pharma GmbH has 1 investors on record on gritt.io and 1 late-stage investors.
When did NEUWAY Pharma GmbH last raise funding?
The most recent investment in NEUWAY Pharma GmbH recorded on gritt.io was in 2022.
When was NEUWAY Pharma GmbH founded?
NEUWAY Pharma GmbH was founded in 2014.
What industry is NEUWAY Pharma GmbH in?
NEUWAY Pharma GmbH operates in Research Services. Find similar Research Services investors on gritt.io.
Where is NEUWAY Pharma GmbH based?
NEUWAY Pharma GmbH is headquartered in Bonn, Germany.